Zilver® PTX® Drug-Eluting Peripheral Stent

Description

Zilver PTX Drug-Eluting Peripheral StentHandle of the Zilver PTX delivery system Used in the treatment of symptomatic vascular disease of the above-the-knee femoropopliteal arteries having reference vessel diameter 4 mm to 7 mm. To avoid involvement of the common femoral artery, the proximal end of the stent should be placed at least 1 cm below the origin of the superficial femoral artery. To...

Full description

Technical Specifications

Reference Part Number Stent diameter (Fr) Length of stent (cm) Wire Guide (inch) Diameter Shaft (Fr) Shaft Length (cm)
ZISV6-35-125-5.0-120-PTX 5 120 0,035 6 125
ZISV6-35-125-6.0-100-PTX 6 100 0,035 6 125
ZISV6-35-125-6.0-120-PTX 6 120 0,035 6 125
ZISV6-35-125-7.0-100-PTX 7 100 0,035 6 125
ZISV6-35-125-7.0-120-PTX 7 120 0,035 6 125
ZISV6-35-125-8.0-100-PTX 8 100 0,035 6 125
ZISV6-35-125-8.0-120-PTX 8 120 0,035 6 125
ZISV6-35-125-8.0-40-PTX 8 40 0,035 6 125

Partner

Zilver® PTX® Drug-Eluting Peripheral Stent

Zilver PTX Drug-Eluting Peripheral StentHandle of the Zilver PTX delivery system Used in the treatment of symptomatic vascular disease of the above-the-knee femoropopliteal arteries having reference vessel diameter 4 mm to 7 mm. To avoid involvement of the common femoral artery, the proximal end of the stent should be placed at least 1 cm below the origin of the superficial femoral artery. To avoid involvement of the below-the-knee popliteal artery, the distal end of the stent should be placed above the plane of the femoral epicondyles.